402 related articles for article (PubMed ID: 19290488)
1. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.
Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M
Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488
[TBL] [Abstract][Full Text] [Related]
2. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer.
Peng Z; Wei D; Wang L; Tang H; Zhang J; Le X; Jia Z; Li Q; Xie K
Clin Cancer Res; 2006 Nov; 12(21):6386-94. PubMed ID: 17085650
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
4. [Reappraisal of the impacts of human Runt-related transcription factor gene 3 expression on differentiation and prognosis of gastric cancer].
Wu BW; Zhang J; Fei XF; Zhu ZG; Cao WX
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar; 10(2):165-8. PubMed ID: 17380460
[TBL] [Abstract][Full Text] [Related]
5. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
7. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
[TBL] [Abstract][Full Text] [Related]
8. Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis.
Wei D; Gong W; Oh SC; Li Q; Kim WD; Wang L; Le X; Yao J; Wu TT; Huang S; Xie K
Cancer Res; 2005 Jun; 65(11):4809-16. PubMed ID: 15930301
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic pathway induced by transduction of RUNX3 in the human gastric carcinoma cell line MKN-1.
Nagahama Y; Ishimaru M; Osaki M; Inoue T; Maeda A; Nakada C; Moriyama M; Sato K; Oshimura M; Ito H
Cancer Sci; 2008 Jan; 99(1):23-30. PubMed ID: 17956589
[TBL] [Abstract][Full Text] [Related]
10. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
11. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
12. Runx3 controls growth and differentiation of gastric epithelial cells in mammals.
Fukamachi H
Dev Growth Differ; 2006 Jan; 48(1):1-13. PubMed ID: 16466388
[TBL] [Abstract][Full Text] [Related]
13. Expression of RUNX3 in salivary adenoid cystic carcinoma: implications for tumor progression and prognosis.
He JF; Ge MH; Zhu X; Chen C; Tan Z; Li YN; Gu ZY
Cancer Sci; 2008 Jul; 99(7):1334-40. PubMed ID: 18410404
[TBL] [Abstract][Full Text] [Related]
14. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
[TBL] [Abstract][Full Text] [Related]
15. Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis.
Sakakura C; Miyagawa K; Fukuda KI; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ida H; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Ito K; Hagiwara A; Ito Y
Oncogene; 2007 Aug; 26(40):5927-38. PubMed ID: 17384682
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer.
Kitajima Y; Ohtaka K; Mitsuno M; Tanaka M; Sato S; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jan; 19(1):197-202. PubMed ID: 18097595
[TBL] [Abstract][Full Text] [Related]
19. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.
Chang TL; Ito K; Ko TK; Liu Q; Salto-Tellez M; Yeoh KG; Fukamachi H; Ito Y
Gastroenterology; 2010 Jan; 138(1):255-65.e1-3. PubMed ID: 19706291
[TBL] [Abstract][Full Text] [Related]
20. Runx3-/- gastric epithelial cells differentiate into intestinal type cells.
Fukamachi H; Ito K; Ito Y
Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
